Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its own version of Novo Nordisk’s Wegovy oral weight-loss drug.
www.marketwatch.com
#Hims #amp #stock #poised #heavy #losses #quick #Uturn #plan #oral #Wegovy #competitor
Hims & Hers stock poised for heavy losses after quick U-turn on plan for oral Wegovy competitor
